The inflammation process remains a driving force in the progression of cancer, promoting its development through the production of inflammatory cytokines [84], with microbial dysbiosis leading to increased concentrations of interleukin (IL)-1, 6, 10, and tumor necrosis factor alpha (TNF-α). This evidence concerns the gene TNF and cancer.